Insider · CIK 0001644975
Jon Congleton
Files at MLYS (Mineralys Therapeutics, Inc.). First filing Oct 15, 2024, latest Oct 2, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MLYS: Mineralys Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Mineralys Therapeutics, Inc. | $1.9M 75,000 shares | -12% | +12% from low-47% from high | |
| 17Weak | Mineralys Therapeutics, Inc. | $187k 15,319 shares | -2% | +53% from low-21% from high | |
| 16Weak | Mineralys Therapeutics, Inc. | $166k 18,333 shares | -2% | - | |
| 25Weak | Mineralys Therapeutics, Inc. | $206k 15,271 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | MLYS Mineralys Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -75,000 | $25.46 | $1.9M | 528,621 | 10 d ago |
| Apr 11, 2025 | MLYS Mineralys Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,319 | $12.19 | $187k | 862,289 | Apr 15, 2025 |
| Feb 13, 2025 | MLYS Mineralys Therapeutics, Inc. | AGrant or award Stock Optionderivative | +570,000 | $0.00 | $0 | 570,000 | Feb 24, 2025 |
| Jan 13, 2025 | MLYS Mineralys Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -18,333 | $9.06 | $166k | 877,608 | Jan 15, 2025 |
| Oct 11, 2024 | MLYS Mineralys Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,271 | $13.52 | $206k | 895,941 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.